Commentary
2020-11-17
比亞迪捱沽後反彈 吼新上市55380牛/55381熊
再有藥廠迎來疫苗研發好消息,隔夜美股受消息刺激向好,其中道指及標普500指數雙雙創下新高。大市今日(17日)或有望隨外圍再度向好,惟26500點水平可能見阻力。看好可留意新上市恆指牛證55356,收回價26068點,換股比率10000:1。相反看淡則可留意恆指熊證57795,收回價26750點,實際槓桿48.85倍,換股比率10000:1。
 
日前同樣被視為染藍大熱之一的比亞迪股份(01211)上日曾經急跌逾8%,日內低位貼近20天線(約164元),惟午後跌幅顯著收窄並以全日高位收市,向上觀望重上200元關口。看好可留意新上市比迪牛證55380,收回價160元,換股比率100:1,或留意比迪購證15813,行使價221.1元,實際槓桿3.08倍,21年5月到期。相反看淡亦可留意同為新上市比迪熊證55381,收回價202元,換股比率100:1,或比迪沽證15828,行使價148.88元,實際槓桿2.8倍,21年5月到期。
 
受美國行政命令影響的中國移動(00941)上日捱沽急跌3.7%並失守50元水平。有大行發表報告指是次禁令將不損集團基本營運面,故維持中移動「跑贏大市」評級及目標價。參考輪證資金動向,上日有逾2590萬元淨流入中移動好倉部署博反彈。投資者如看好可留意中移購證28610,行使價58.93元,實際槓桿10.85倍,21年3月到期。相反看淡亦可留意輕微價內中移沽證26200,行使價49.45元,實際槓桿9.92倍,20年12月到期,惟投資者須注意到期風險。
The information on this website is provided by Haitong International Securities Company Limited (“HTI”), a corporation licensed by the Securities and Futures Commission (”SFC”). The contents of this website has not been reviewed or approved by the SFC. Structured products issued by HTI or its affiliate are non-collateralized and investors are relying on the issuer’s credit worthiness in determining the issuer’s ability to meet its obligations under the structured products. If the Issuer is insolvent or defaults in payment, investors may not recover part or all of the amount due. Any and all information provided on this website is for reference only and does not constitute an offer, a solicitation of an offer or any advice or recommendation to buy or sell any financial products. The prices of Warrants and/or CBBCs (“Structured Products”) may fluctuate greatly and past performance is not indicative of future performance. The value of structured products may become zero on or before the expiry date and investors may sustain a total loss of investment. CBBCs have a mandatory call feature and are subject to early termination, upon which (i) investors in category N CBBCs will lose all their investments in CBBCs; and (ii) the residual value of category R CBBCs may be zero. Inline warrants have been newly introduced to the market and there are no similar products currently listed on the Stock Exchange of Hong Kong Limited for comparison. Inline warrants carry exotic features, and their terms and pricing may be more complicated than standard derivative warrants. Maximum potential payoff is fixed and capped. Price movement of the inline warrants may be disproportionate or opposite to the price movement of the underlying asset. An investor should read carefully the relevant listing documents (and any documents appendix thereto) and the relevant supplemental listing document to understand the full details of the warrant and/or CBBC (including risk factors), and due consideration have been given having considered the nature and risks involved in investing in these products, to decide whether the investment is suitable for an investor’s individual circumstances and, if necessary, an investor should consult their professional advisers. HTI is also the liquidity provider for the structured products issued by itself. HTI may be the only person quoting prices (or market making) for the structured products on the exchange. As such, the secondary market for the structured products may be limited. HTI (together with its subsidiaries and affiliates, “HTI Group”) provides the information in good faith and has used its best endeavours to ensure that the information provided is accurate and complete. HTI Group however does not represent or warrant the completeness or accuracy of the information and HTI Group accepts no responsibility or liability whatsoever for the completeness or accuracy of the information. HTI and/or its group company(ies) may have presently, or have had within the last 12 months, an investment banking relationship with the underlying entity of the securities herein covered. HTI is a member of Haitong International Securities Group which in turn belongs to group of companies of Haitong Securities Co., Ltd. HTI and/or its group company(ies) and its affiliates, officers, directors, and employees (excluding the producer responsible for the content of this document) will from time to time have long or short positions in, act as principal in, and buy or sell, the securities or derivatives, if any, referred to in this document.
Date Title Download
2022-04-29 友邦今放榜金沙績後走弱 分吼56537牛/21285購  
2022-04-28 滙豐四連跌中海油今放榜 分吼65076牛/50308牛  
2022-04-27 港交所比亞迪今放榜 分吼57577牛/23789購  
2022-04-26 滙控今放榜友邦三連跌 分吼22327購/29670購  
2022-04-25 阿里六連跌港交所逆市升 分吼11989購/28215購  
2022-04-22 小米考驗前底滙控逆市三連升 分吼29102購/22327購  
2022-04-21 阿里四連跌港交所見一個月低 分吼20611購/28215購  
2022-04-20 美團遭約談平保失守10天線 分吼11091購/29660購  
2022-04-19 比亞迪三連升友邦爭持 分吼12815購/27756購  
2022-04-14 美團靠穩中海油收復10天線 分吼11091購/50308牛  
2022-04-13 騰訊終止四連跌快手捱沽 分吼11996購/11990購  
2022-04-12 車股受壓 留意長汽11067購/比迪23789購/吉利57580牛  
2022-04-11 美團遭大手減持友邦創逾一個月高位 分吼11091購/21528購  
2022-04-08 比亞迪失守250天線銀娛捱沽 分吼12815購/54003熊  
2022-04-07 阿里失守50天線中海油逆市走強 分吼20611購/50308牛  
2022-04-06 美團創一個月高位平保重拾100天線 分吼26697購/29660購  
2022-04-04 騰訊收復20天線遠海去年多賺8倍 分吼11996購/22330購  
2022-04-01 滙豐逆市升中海油回A獲批 分吼22327購/24486購  
2022-03-31 友邦收復50天線比亞迪績後靠穩 分吼58755牛/23789購  
2022-03-30 中海油今放榜快手虧損擴大 分吼24486購/19684購